Lymphangiomyomatosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Infobox_Disease | {{Infobox_Disease | ||
| Name = {{PAGENAME}} | | Name = {{PAGENAME}} | ||
| Line 11: | Line 8: | ||
| MeshID = D018192 | | MeshID = D018192 | ||
}} | }} | ||
{{Lymphangiomyomatosis}} | |||
{{CMG}}; {{AOEIC}} {{VK}} | |||
{{SK}} Lymphangioleiomyomatosis; LAM | {{SK}} Lymphangioleiomyomatosis; LAM | ||
Revision as of 17:58, 14 September 2012
| Lymphangiomyomatosis | |
 | |
|---|---|
| CT scan of a lung with LAM. | |
| OMIM | 606690 |
| DiseasesDB | ddb30755 |
| MeSH | D018192 |
Template:Lymphangiomyomatosis Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Varun Kumar, M.B.B.S. [2]
Synonyms and keywords: Lymphangioleiomyomatosis; LAM
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Lymphangiomyomatosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | EKG | Chest X ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies